Biomarkers and biomeasures: key enablers for pharmacokinetic–pharmacodynamic modeling in drug discovery and development
SOMAscan™ used to investigate protein expression in non-small-cell lung cancer
Two-layered polymeric membrane prevents hematocrit issues in dried blood spot analysis
Grinding procedure influence on LC–MS/MS determination of ethyl glucuronide concentrations in hair
New ELISA bulks up detection ability of steroid screening methods
New strategic outsourcing program from Metabolon
Conference Report: Bioanalytical sessions at the 2011 Eastern Analytical Symposium
Bioanalysis Young Investigator: Dajana Vuckovic
Bioanalysis Young Investigator: Maria Rambla-Alegre
Implication of free cholesterol in LC–MS response enhancement
Validation study of urinary metabolites as potential biomarkers for prostate cancer detection
Comparison of RP-HPLC columns used for determination of nucleoside metabolic patterns in urine of cancer patients
LC–MS/MS method for simultaneous estimation of candesartan and hydrochlorothiazide in human plasma and its use in clinical pharmacokinetics
A novel UPLC–MS/MS method for simultaneous quantification of rhein, emodin, berberine and baicalin in rat plasma and its application in a pharmacokinetic study
Validation and life-cycle management of a quantitative ligand-binding assay for the measurement of Nulojix®, a CTLA-4–Fc fusion protein, in renal and liver transplant patients
Perspectives on addressing ionization matrix effects in LC–MS bioanalysis
LC–MS metabolomics of polar compounds
Biomarker monitoring in sports doping control
Acknowledgements